Literature DB >> 33160089

Increased serum peripheral C-reactive protein is associated with reduced brain barriers permeability of TSPO radioligands in healthy volunteers and depressed patients: implications for inflammation and depression.

Federico E Turkheimer1, Noha Althubaity2, Julia Schubert2, Maria A Nettis2, Oliver Cousins2, Danai Dima3, Valeria Mondelli2, Edward T Bullmore4, Carmine Pariante2, Mattia Veronese2.   

Abstract

The relationship between peripheral and central immunity and how these ultimately may cause depressed behaviour has been the focus of a number of imaging studies conducted with Positron Emission Tomography (PET). These studies aimed at testing the immune-mediated model of depression that proposes a direct effect of peripheral cytokines and immune cells on the brain to elicit a neuroinflammatory response via a leaky blood-brain barrier and ultimately depressive behaviour. However, studies conducted so far using PET radioligands targeting the neuroinflammatory marker 18 kDa translocator protein (TSPO) in patient cohorts with depression have demonstrated mild inflammatory brain status but no correlation between central and peripheral immunity. To gain a better insight into the relationship between heightened peripheral immunity and neuroinflammation, we estimated blood-to-brain and blood-to-CSF perfusion rates for two TSPO radiotracers collected in two separate studies, one large cross-sectional study of neuroinflammation in normal and depressed cohorts (N = 51 patients and N = 25 controls) and a second study where peripheral inflammation in N = 7 healthy controls was induced via subcutaneous injection of interferon (IFN)-α. In both studies we observed a consistent negative association between peripheral inflammation, measured with c-reactive protein P (CRP), and radiotracer perfusion into and from the brain parenchyma and CSF. Importantly, there was no association of this effect with the marker of BBB leakage S100β, that was unchanged. These results suggest a different model of peripheral-to-central immunity interaction whereas peripheral inflammation may cause a reduction in BBB permeability. This effect, on the long term, is likely to disrupt brain homeostasis and induce depressive behavioural symptoms.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BBB permeability; CSF; Choroid plexus; Depression; Inflammation; PET; Tracer percolation

Mesh:

Substances:

Year:  2020        PMID: 33160089     DOI: 10.1016/j.bbi.2020.10.025

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  16 in total

1.  The Effects of Peripheral Inflammation on the Brain-A Neuroimaging Perspective.

Authors:  Caitlin E Millett; Katherine E Burdick; Marek R Kubicki
Journal:  Harv Rev Psychiatry       Date:  2022 Jan-Feb 01       Impact factor: 3.732

2.  NRM 2021 Abstract Booklet.

Authors: 
Journal:  J Cereb Blood Flow Metab       Date:  2021-12       Impact factor: 6.960

3.  Elevated C-Reactive Protein in Alzheimer's Disease Without Depression in Older Adults: Findings From the Health and Retirement Study.

Authors:  Ginny Natale; Sean A P Clouston; Dylan M Smith
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2022-04-01       Impact factor: 6.591

Review 4.  Applicability, potential and limitations of TSPO PET imaging as a clinical immunopsychiatry biomarker.

Authors:  Livia J De Picker; Benno C M Haarman
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-18       Impact factor: 9.236

5.  A Modest Increase in 11C-PK11195-Positron Emission Tomography TSPO Binding in Depression Is Not Associated With Serum C-Reactive Protein or Body Mass Index.

Authors:  Julia J Schubert; Mattia Veronese; Tim D Fryer; Roido Manavaki; Manfred G Kitzbichler; Maria A Nettis; Valeria Mondelli; Carmine M Pariante; Edward T Bullmore; Federico E Turkheimer
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2021-01-28

Review 6.  Inflammation-driven brain and gut barrier dysfunction in stress and mood disorders.

Authors:  Ellen Doney; Alice Cadoret; Laurence Dion-Albert; Manon Lebel; Caroline Menard
Journal:  Eur J Neurosci       Date:  2021-05-17       Impact factor: 3.698

Review 7.  Chinese Herbal Medicine for the Treatment of Depression: Effects on the Neuroendocrine-Immune Network.

Authors:  Chan Li; Bishan Huang; Yuan-Wei Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-01-14

8.  Cortical inflammation and brain signs of high-risk atherosclerosis in a non-human primate model.

Authors:  Vanessa Di Cataldo; Justine Debatisse; Joao Piraquive; Alain Géloën; Clément Grandin; Michaël Verset; Fabrice Taborik; Emmanuel Labaronne; Emmanuelle Loizon; Antoine Millon; Pauline Mury; Vincent Pialoux; André Serusclat; Franck Lamberton; Danielle Ibarrola; Franck Lavenne; Didier Le Bars; Thomas Troalen; Joachim Confais; Claire Crola Da Silva; Laura Mechtouff; Hugues Contamin; Zahi A Fayad; Emmanuelle Canet-Soulas
Journal:  Brain Commun       Date:  2021-04-01

9.  What can neuroimmunology teach us about the symptoms of long-COVID?

Authors:  Valeria Mondelli; Carmine M Pariante
Journal:  Oxf Open Immunol       Date:  2021-02-10

10.  Ketamine's effect on inflammation and kynurenine pathway in depression: A systematic review.

Authors:  Emma Kopra; Valeria Mondelli; Carmine Pariante; Naghmeh Nikkheslat
Journal:  J Psychopharmacol       Date:  2021-06-26       Impact factor: 4.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.